These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 420467)

  • 1. NIH conference. Primary biliary cirrhosis and the complement system.
    Ann Intern Med; 1979 Jan; 90(1):72-84. PubMed ID: 420467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.
    Jaffe CJ; Vierling JM; Jones EA; Lawley TJ; Frank MM
    J Clin Invest; 1978 Nov; 62(5):1069-77. PubMed ID: 711852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective elimination of C3b/iC3b-coated autologous erythrocytes in patients with primary biliary cirrhosis, alcoholic cirrhosis, and ulcerative colitis.
    Nilsson Ekdahl K; Lööf L; Ahrenstedt O; Nilsson UR; Nilsson B
    J Lab Clin Med; 1997 Sep; 130(3):285-92. PubMed ID: 9341988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mononuclear cell complement receptor blockade in primary biliary cirrhosis.
    Al-Aghbar MN; Neuberger J; Williams R; Eddleston AL
    Gut; 1985 Jan; 26(1):20-5. PubMed ID: 3155513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
    Brown EJ; Joiner KA; Frank MM
    J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement system is not activated in primary biliary cirrhosis.
    Gardinali M; Conciato L; Cafaro C; Crosignani A; Battezzati PM; Agostoni A; Podda M
    Clin Immunol Immunopathol; 1998 Jun; 87(3):297-303. PubMed ID: 9646840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis.
    Minuk GY; Vergalla J; Hanson RG; Hoofnagle JH; Frank MM; Jones EA
    Gut; 1986 Mar; 27(3):324-8. PubMed ID: 3009280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes.
    Edberg JC; Tosic L; Wright EL; Sutherland WM; Taylor RP
    J Immunol; 1988 Dec; 141(12):4258-65. PubMed ID: 3198918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective Fc receptor-mediated clearance in patients with primary biliary cirrhosis.
    Ekdahl KN; Lööf L; Nyberg A; Nilsson UR; Nilsson B
    Gastroenterology; 1991 Oct; 101(4):1076-82. PubMed ID: 1889700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes and complement activation in primary biliary cirrhosis.
    Wands JR; Dienstag JL; Bhan AK; Feller ER; Isselbacher KJ
    N Engl J Med; 1978 Feb; 298(5):233-7. PubMed ID: 619265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in chronic liver disease.
    Munoz LE; De Villiers D; Markham D; Whaley K; Thomas HC
    Clin Exp Immunol; 1982 Mar; 47(3):548-54. PubMed ID: 7083631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation in primary biliary cirrhosis: an in vitro model.
    Lindgren S; Johnson U
    J Lab Clin Med; 1985 Apr; 105(4):432-5. PubMed ID: 3872338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An indirect effect of an antibody on complement deposition and lysis of differently sensitized surrounding cells.
    Bakács T; Lutz HU; Tusnády G; Varga L; Merry AH; Sim RR
    Mol Immunol; 1994 Aug; 31(12):901-11. PubMed ID: 8065373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis.
    Potter BJ; Elias E; Thomas HC; Sherlock S
    Gastroenterology; 1980 May; 78(5 Pt 1):1034-40. PubMed ID: 7380176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G.
    Griffin FM; Bianco C; Silverstein SC
    J Exp Med; 1975 Jun; 141(6):1269-77. PubMed ID: 1092796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
    Atkinson JP; Frank MM
    J Clin Invest; 1974 Aug; 54(2):339-48. PubMed ID: 4847248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the endocytosis of immune complexes.
    van Es LA; Daha MR
    Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is primary biliary cirrhosis an immune complex disease?
    Thomas HC; Potter BJ; Sherlock S
    Lancet; 1977 Dec; 2(8051):1261-3. PubMed ID: 73956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.
    Yokoyama I; Waxman F
    Immunology; 1993 Oct; 80(2):168-76. PubMed ID: 8262546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible contribution of the complement system to the inflammatory state.
    Hadding U
    Agents Actions Suppl; 1980; 7():24-32. PubMed ID: 7018199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.